Inpatient Care - Israel

Israel

The Inpatient Care market in Israel is expected to witness significant growth in the coming years.
According to projections, the revenue in this market is estimated to reach US$9.68bn by 2024.
Furthermore, it is anticipated that the market will demonstrate a steady annual growth rate of 3.90% between 2024 and 2029.
This growth trajectory is expected to result in a market volume of US$11.72bn by 2029.
When compared globally, it is worth noting that in the United States is forecasted to generate the highest revenue in the Inpatient Care market.
In 2024 alone, in the United States is projected to contribute a significant amount of US$731.40bn to the market.
Israel's inpatient care market is experiencing a surge in medical tourism, with patients flocking to the country for its advanced healthcare facilities and highly skilled doctors.

Key regions: India, Canada, Japan, United Kingdom, Germany

Market

Region

Region comparison

Currency

Analyst Opinion

The Inpatient Care market in Israel has been growing steadily in recent years due to various factors.

Customer preferences: Patients in Israel prefer to receive medical treatment in hospitals rather than at home. This is due to the high quality of care provided by hospitals and the availability of modern medical equipment. Additionally, many patients prefer to have access to a wide range of medical specialists, which is often only available in hospitals.

Trends in the market: One of the major trends in the Inpatient Care market in Israel is the increasing demand for private hospitals. Private hospitals are becoming more popular due to the shorter waiting times for treatment and the higher level of comfort provided to patients. Additionally, many private hospitals offer specialized treatments that are not available in public hospitals.Another trend in the market is the increasing use of technology in healthcare. Israeli hospitals are known for their advanced medical technologies, and this trend is expected to continue in the future. For example, there is a growing use of telemedicine in Israel, which allows patients to receive medical consultations and treatment remotely.

Local special circumstances: Israel has a unique healthcare system that is a combination of public and private healthcare. The government provides universal healthcare coverage to all citizens, but many Israelis also choose to purchase private health insurance to supplement their coverage. This has led to a dual system of public and private hospitals, which has contributed to the growth of the Inpatient Care market in Israel.

Underlying macroeconomic factors: The Israeli economy has been growing steadily in recent years, which has led to an increase in healthcare spending. Additionally, Israel has a rapidly growing population, which has led to an increased demand for healthcare services. Finally, Israel is known for its strong innovation and technology sectors, which has led to the development of many advanced medical technologies that are used in hospitals throughout the country.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on revenue received by hospitals from public or private sources, allocated to the country where the money is spent, including VAT if applicable.

Modeling approach / Market size:

Market sizes are determined by a bottom-up approach, based on a specific rationale for each market market. Next, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, public health spend, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.